학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 591건 | 목록 1~10
Academic Journal
Rodriguez-Vida A; Medical Oncology Department, Hospital del Mar, CIBERONC, Barcelona.; Valderrama BP; Medical Oncology Department, Hospital Universitario Virgen del Rocío, Sevilla.; Castellano D; Medical Oncology Department, Hospital 12 de Octubre, Madrid.; Pinto A; Medical Oncology Department, Hospital La Paz, Madrid.; Mellado B; Medical Oncology Department, Hospital Clínic, Laboratory of Traslational Genomics in Solid Tumors, IDIBAPS, University of Barcelona, Barcelona.; Puente J; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), CIBERONC, Madrid.; Climent MA; Medical Oncology Department, Instituto Valenciano de Oncología, Valencia.; Domenech M; Medical Oncology Department, Hospital Althaia, Manresa.; Vazquez F; Medical Oncology Department, Hospital General Universitario de Elche, Alicante.; Perez-Gracia JL; Oncology Department, Clínica Universidad de Navarra, Pamplona.; Bonfill T; Medical Oncology Department, Hospital Universitario Parc Taulí, Sabadell.; Morales-Barrera R; Medical Oncology Department, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona.; Gonzalez-Billalabeitia E; Medical Oncology Department, Hospital 12 de Octubre, Madrid; Medical Oncology Department, Hospital Morales Meseguer, Murcia.; Garcia-Del-Muro X; Medical Oncology Department, Institut Català d'Oncologia IDIBELL Research Institute, University of Barcelona, Barcelona.; Maroto P; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona.; Navarro-Gorro N; Medical Oncology Department, Hospital del Mar, CIBERONC, Barcelona.; Juanpere N; Pathology Department, Hospital del Mar, IMIM Research Institute, Barcelona.; Juan O; Medical Oncology, Pivotal S.L.U., Clinical Research Organisation, Madrid, Spain.; Bellmunt J; Medical Oncology Department, Hospital del Mar, CIBERONC, Barcelona; Dana Farber Cancer Center, Harvard Medical School, Boston, USA. Electronic address: Joaquim_Bellmunt@dfci.harvard.edu.
Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Academic Journal
Jiménez N; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain.; Garcia de Herreros M; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain.; Reig Ò; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain; Uro-Oncology Unit, Hospital Clínic, University of Barcelona, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain.; Marín-Aguilera M; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain.; Aversa C; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain; Uro-Oncology Unit, Hospital Clínic, University of Barcelona, Barcelona, Spain.; Ferrer-Mileo L; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain; Uro-Oncology Unit, Hospital Clínic, University of Barcelona, Barcelona, Spain.; García-Esteve S; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain.; Rodríguez-Carunchio L; Uro-Oncology Unit, Hospital Clínic, University of Barcelona, Barcelona, Spain; Department of Pathology, Hospital Clínic, Barcelona, Spain.; Trias I; Uro-Oncology Unit, Hospital Clínic, University of Barcelona, Barcelona, Spain; Department of Pathology, Hospital Clínic, Barcelona, Spain.; Font A; Medical Oncology Department, Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Badalona, Spain.; Rodriguez-Vida A; Medical Oncology Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, Barcelona, Spain.; Climent MÁ; Medical Oncology Service, Instituto Valenciano de Oncología (IVO), Valencia, Spain.; Cros S; Medical Oncology Department, Hospital General de Granollers, Barcelona, Spain.; Chirivella I; Oncology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.; Domènech M; Medical Oncology Department, Fundació Althaia, Xarxa Assistencial Universitària de Manresa, Spain.; Figols M; Medical Oncology Department, Fundació Althaia, Xarxa Assistencial Universitària de Manresa, Spain.; Carles J; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.; Suárez C; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.; Herrero Rivera D; Medical Oncology Department, Hospital Virgen del Rocío, Sevilla, Spain.; González-Billalabeitia E; Medical Oncology Department, University Hospital, 12 de Octubre, Madrid, Spain.; Cívico C; Department of Hematology and Medical Oncology, Hospital Universitario Morales Meseguer, IMIB-Universidad de Murcia, Murcia, Spain.; Sala-González N; Department of Medical Oncology, Institut Català d'Oncologia, Girona, Spain.; Ruiz de Porras V; Badalona Applied Research Group in Oncology (B-ARGO), Institut Català d'Oncologia - Germans Trias i Pujol Research Institute, Badalona, Spain.; Ribal MJ; Department of Urology, Hospital Clínic, Barcelona, Spain.; Prat A; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain.; Mellado B; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain; Uro-Oncology Unit, Hospital Clínic, University of Barcelona, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain. Electronic address: bmellado@clinic.cat.
Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE
Academic Journal
Bellmunt J; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA; Cancer Research Program, Hospital del Mar Research Institute, Barcelona, Spain. Electronic address: Joaquim_Bellmunt@dfci.harvard.edu.; Maroto P; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Bonfill T; Department of Medical Oncology, Hospital Universitari Parc Taulí, Sabadell, Spain.; Vazquez F; Department of Medical Oncology, Hospital General Universitario de Elche, Alicante, Spain.; Perez-Gracia JL; Department of Medical Oncology, Clínica Universidad de Navarra, Pamplona, Spain.; Juanpere N; Department of Pathology, Hospital del Mar, Barcelona, Spain.; Hernandez-Prat A; Cancer Research Program, Hospital del Mar Research Institute, Barcelona, Spain.; Hernandez-Llodra S; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.; Rovira A; Cancer Research Program, Hospital del Mar Research Institute, Barcelona, Spain.; Juan O; Senior Medical Manager Pivotal S.L.U. Madrid, Spain.; Rodriguez-Vida A; Cancer Research Program, Hospital del Mar Research Institute, Barcelona, Spain; Department of Medical Oncology, Hospital del Mar, CIBERONC, Barcelona, Spain.
Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE
Academic Journal
Robbrecht D; Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Grob JJ; Dermatology and Oncology Service, Aix Marseille University and Timone Hospital, Marseille, France.; Bechter O; Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, KU Leuven, Leuven, Belgium.; Simonelli M; Department of Biomedical Science, Humanitas University, Milan, Italy.; Department of Medical Oncology and Hematology, IRCCS Humanitas Research Hospital, Milan, Italy.; Doger B; START Madrid-FJD, Early Phase Clinical Trials Unit, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.; Borbath I; Department of Hepatogastroenterology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.; Butler MO; Department of Medical Oncology and Hematology, Department of Immunology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.; Cheng T; Division of Medical Oncology, Department of Oncology, University of Calgary, Calgary, Alberta, Canada.; Romano PM; Département d'Innovation Thérapeutique et d'Essais Précoces, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Pons-Tostivint E; Service d'oncologie médicale, CHU Nantes, Université de Nantes, Nantes, France.; Di Nicola M; Unit of Immunotherapy and Anticancer Innovative Therapeutics, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.; Curigliano G; Division of Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Ryu MH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.; Rodriguez-Vida A; Medical Oncology Department, Hospital del Mar, CIBERONC, IMIM Research Institute, Barcelona, Spain.; Schadendorf D; Department of Dermatology, University Hospital Essen, Essen, Germany.; German Cancer Consortium, partner site Essen, Essen, Germany.; NCT-West, Campus Essen, Essen, Germany.; University Alliance Ruhr, Research Center One Health, University Duisburg-Essen, Essen, Germany.; Garralda E; Medical Oncology Department, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain.; Abbadessa G; Sanofi, Bridgewater, New Jersey, USA.; Demers B; Sanofi, Vitry-Sur-Seine, France.; Amrate A; Sanofi, Vitry-Sur-Seine, France.; Wang H; Sanofi, Cambridge, Massachusetts, USA.; Lee JS; Sanofi, Cambridge, Massachusetts, USA.; Pomponio R; Sanofi, Cambridge, Massachusetts, USA.; Wang R; Sanofi, Cambridge, Massachusetts, USA.
Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Rodriguez-Vida, A.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어